First Eagle Investment Management, LLC Neuronetics, Inc. Transaction History

First Eagle Investment Management, LLC

$44.4 Billion
Q2 2024

A detailed history of First Eagle Investment Management, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, First Eagle Investment Management, LLC holds 1,039,009 shares of STIM stock, worth $779,256. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,039,009

Previous 779,009 33.38%

Holding current value

$779,256

Previous $3.71 Million 49.57%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.73 - $4.81 $449,800 - $1.25 Million	260,000 Added 33.38%	1,039,009 $1.87 Million
Q1 2024 May 09, 2024	BUY	$2.68 - $4.8 $8,040 - $14,400	3,000 Added 0.39%	779,009 $3.71 Million
Q3 2023 Nov 08, 2023	BUY	$1.29 - $2.22 $252,625 - $434,751	195,834 Added 33.75%	776,009 $1.05 Million
Q2 2023 Aug 09, 2023	BUY	$2.07 - $2.92 $127,897 - $180,415	61,786 Added 11.92%	580,175 $1.25 Million
Q1 2023 May 11, 2023	BUY	$2.81 - $6.71 $422,893 - $1.01 Million	150,496 Added 40.91%	518,389 $1.51 Million
Q4 2022 Feb 09, 2023	BUY	$2.74 - $6.87 $57,816 - $144,963	21,101 Added 6.08%	367,893 $2.53 Million
Q3 2022 Nov 10, 2022	BUY	$2.35 - $4.66 $54,050 - $107,180	23,000 Added 7.1%	346,792 $1.1 Million
Q2 2022 Aug 10, 2022	SELL	$2.09 - $3.71 $32,762 - $58,157	-15,676 Reduced 4.62%	323,792 $1.04 Million
Q1 2022 May 11, 2022	BUY	$2.84 - $4.52 $339,621 - $540,524	119,585 Added 54.39%	339,468 $1.03 Million
Q4 2021 Feb 10, 2022	BUY	$3.87 - $6.59 $628,929 - $1.07 Million	162,514 Added 283.28%	219,883 $981,000
Q3 2021 Nov 10, 2021	BUY	$6.22 - $15.54 $336,066 - $839,626	54,030 Added 1618.15%	57,369 $376,000
Q2 2021 Aug 11, 2021	BUY	$10.15 - $17.25 $33,890 - $57,597	3,339 New	3,339 $53,000

Others Institutions Holding STIM

# of Institutions

Shares Held

18.3M

Call Options Held

Put Options Held

3.8K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $20.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Eagle Investment Management, LLC with notifications on news.

Account

First Eagle Investment Management, LLC Neuronetics, Inc. Transaction History